🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-18
Trial ID
NCT06878833
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested
This is a Phase 1, randomized, double-blinded, placebo-controlled, single a...
Status
Completed
Location
CMAX Clinical Research Pty Ltd
Start Date
2025-03-12
Trial ID
NCT06870058
Treatments Being Tested
The primary purpose of this first-in-man study is to investigate whether a ...
Status
Completed
Location
Investigator Site
Start Date
2016-02-01
Trial ID
NCT02702648
The purpose of this study is to assess the safety, tolerability and pharmac...
Status
Completed
Location
Quotient Sciences-Miami, Inc
Start Date
2023-06-27
Trial ID
NCT05950906
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
This is a First in Human (FIH), double-blinded, parallel-group, randomised,...
Status
Completed
Location
CTC Clinical Trial Consultants AB
Start Date
2019-07-03
Trial ID
NCT04036227
The purpose of this study is to evaluate the effectiveness of niraparib in ...
Status
Active Not Recruiting
Location
Urology Centers Of Alabama
Start Date
2019-01-25
Trial ID
NCT03748641